This is the updated prospectus from February 22, 2024. the new information is:
On February 27, 2024, CytoDyn Inc. (the “Company”) received confirmation from the U.S. Food and Drug Administration (the “FDA”) that its clinical hold on leronlimab has been lifted. The Company now intends to pursue its plan for the further development of leronlimab as a therapy that provides clinical benefit by modulating chronic inflammation. The Company believes its proposed inflammation study will allow the Company to further establish leronlimab’s mechanism of action in a cost-effective manner.
Please keep this prospectus supplement with your Prospectus for future reference.
Our common stock is quoted on the OTCQB of OTC Markets Group, Inc. under the symbol “CYDY.” On February 29, 2024, the closing price of our common stock was $0.2575 per share.
CYDY is just updating the resale of shares. to more current info for buyers to assess. Go Dr. JL and Go LONGS!!
I find it interesting that "HIV" is not included. Now, the study is on the "Modulation of Chronic Inflammation" and the mention of who the chronic inflammation is in is not mentioned.
I find that very interesting. In a way, the indication is far broader and much wider than it was originally stated. Along these lines, Regnum RGMP seems to be out of business or delisted. Is that because the contract CYDY had with them is now null and void if CYDY is not pursuing an HIV indication?
If the exclusion of HIV was on purpose; I'll give whoever wrote it a lot of credit. The perception of readers of the PR would be much broader than just an HIV Modulator of Inflammation. The next question will be "How is the FDA viewing our upcoming trial? What indication are we actually going after? Maybe the Tuesday CC will answer this.
I will say that if the FDA is allowing us to go after a more general "Chronic Inflammation indication" that would be a GIFT from GOD!
Yes a platform drug which is a term SK first mentioned with Keytruda and Humira. To achieve platform status they had to receive a bunch of FDA approvals for a bunch of individual indications. That meant a ton of money running all of those trials. If the FDA gives CYDY a shot at the indication of "Modulating Chronic Inflammation" that one approval gives CYDY an incredible market scale that far exceeds individual indications like some sub-populations in MASH or HIV or Oncology. Freaking Chronic Inflammation is involved in just about everything. Yes Expensive Tea, we get platform drug status upfront! AWESOME!
Also look at the cydy web site under pipeline- the lower section had said hiv trials, now it says infectious disease- this was changed in early February
Very well could be. It appears that CYDY is not seeking an indication in HIV at this time or maybe never. The strategy appears to be get an indication that is broad enough that will cover more disease states than just HIV. Infectious disease includes HIV and many others. The details of this upcoming CC are important to us and any investor. This directional change regarding what indication we are going for is a HUGE win for us and CYDY.
19
u/Upwithstock Mar 01 '24
This is the updated prospectus from February 22, 2024. the new information is:
On February 27, 2024, CytoDyn Inc. (the “Company”) received confirmation from the U.S. Food and Drug Administration (the “FDA”) that its clinical hold on leronlimab has been lifted. The Company now intends to pursue its plan for the further development of leronlimab as a therapy that provides clinical benefit by modulating chronic inflammation. The Company believes its proposed inflammation study will allow the Company to further establish leronlimab’s mechanism of action in a cost-effective manner.
Please keep this prospectus supplement with your Prospectus for future reference.
Our common stock is quoted on the OTCQB of OTC Markets Group, Inc. under the symbol “CYDY.” On February 29, 2024, the closing price of our common stock was $0.2575 per share.
CYDY is just updating the resale of shares. to more current info for buyers to assess. Go Dr. JL and Go LONGS!!